Navidea Biopharmaceuticals, inc. (NAVB)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

4995 BRADENTON AVENUE DUBLIN, OH 43017

Navidea Biopharm manufactures a line of gamma radiation detection equipment used in the application of intraoperative lymphatic mapping. The company is also developing and commercializing a line of blood flow monitoring devices for a variety of diagnostic and surgical applications.

Data based on most recent fiscal year report
Market Cap56.791 Million Shares Outstanding162.26 Million Avg Volume726.477 Thousand
1-Yr BETA vs S&P TR1.302 Current Ratio1.71 Quick Ratio1.71
View SEC Filings from NAVB instead.
Q1 2019 All Institutions Hedge Funds 1
To trade NAVB now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 48 5 (0.51%)
Aggregate 13F shares on 03/31/2019: 519.805 Thousand 22.963 Thousand
Aggregate 13F shares on 12/31/2018: 493.779 Thousand 10.292 Thousand
Percent change: 5.27% 123.12%
Funds creating new positions: 4 1
Funds Adding to an existing position: 10 1
Funds closing out their position: 12 1
Funds reducing their position: 4
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

 

Navidea Biopharmaceuticals, inc. Chart by YCharts

Yahoo! Finance

finviz

Check out our reporting and analysis

Funds Holding NAVB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

367.6 Thousand total shares from 7 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LATKIN JED CEO, COO & CFO

  • Officer
  • Director
 11,950 2019-05-16 3

BRUCK CLAUDINE

  • Director
 7,550 2019-05-13 2

DRAKE PETER F

  • 10% Owner
 62,540 2019-05-09 0

KARSEN PERRY A

  • Director
 0 2019-04-23 0

SCOTT JOHN K JR.

  • 10% Owner
 22,464,350 2019-03-22 2

CUTLER ADAM D. SEE REMARKS

  • Officer
 0 2019-02-15 3

RICE YEHUDA MICHAEL

  • Director
 150,000 2019-02-07 1

ROUAN SARAH KATHRYN

  • Director
 100,000 2019-02-07 3

ROSOL MICHAEL STANLEY CHIEF MEDICAL OFFICER

  • Officer
 0 2019-01-02 2

ROWINSKY ERIC K

  • Director
 550,000 2019-01-01 0

COPE FREDERICK O SVP & CSO

  • Officer
 585,052 2018-06-29 1

GUETH ANTON

  • Director
 0 2018-06-08 0

FIORINO ANTHONY S. CHIEF MEDICAL OFFICER AND COO

  • Officer
 75,000 2018-05-22 0

GREENE MARK I

  • Director
 157,244 2018-02-20 0

REGAN WILLIAM J. SVP & CCO

  • Officer
 172,977 2017-06-29 0

GOLDBERG MICHAEL M PRESIDENT & CEO

5,921,023 2017-05-16 0

KLIMA THOMAS J SVP & CHIEF COMMERCIAL OFFICER

  • Officer
 51,935 2017-02-06 0

TROUP GORDON A

  • Director
 No longer subject to file 2016-04-20 0

LARSON BRENT L EVP, CFO, TREAS & SEC'Y

  • Officer
 0 2016-02-25 0

FORD BRENDAN A

  • Director
 239,950 2015-07-31 0

TOMBLYN MICHAEL SVP, CHIEF MED. OFFICER

  • Officer
 100,000 2015-07-02 0

TULIP THOMAS H. CHIEF BUS. OFFICER

  • Officer
 77,966 2015-03-26 0

NORDLICHT MARK

PLATINUM MANAGEMENT (NY) LLC

LANDESMAN URI

PLATINUM LIQUID OPPORTUNITY MANAGEMENT (NY) LLC

PLATINUM PARTNERS LIQUID OPPORTUNITY MASTER FUND L.P.

PLATINUM PARTNERS VALUE ARBITRAGE FUND, LP

PLATINUM-MONTAUR LIFE SCIENCES, LLC

  • 10% Owner
 2,285,346 2014-12-18 0

GONZALEZ RICARDO J CHIEF EXECUTIVE OFFICER

  • Officer
 0 2014-10-13 0

NORDLICHT MARK

PLATINUM MANAGEMENT (NY) LLC

PLATINUM PARTNERS VALUE ARBITRAGE FUND, LP

LANDESMAN URI

PLATINUM LIQUID OPPORTUNITY MANAGEMENT (NY) LLC

PLATINUM PARTNERS LIQUID OPPORTUNITY MASTER FUND L.P.

  • 10% Owner
 15,106,431 2014-08-12 0

PYKETT MARK JEROME

  • Director
 318,505 2014-06-01 0

REININGER CORNELIA SVP & CHIEF MEDICAL OFFICER

  • Officer
 0 2014-01-28 0

PLATINUM-MONTAUR LIFE SCIENCES, LLC

PLATINUM PARTNERS VALUE ARBITRAGE FUND, LP

  • 10% Owner
  • SEE EXPLANATION OF RESPONSES
10,073,375 2013-11-13 0

BROWN RODGER A VICE PRESIDENT

  • Officer
 123,027 2013-03-13 0

JONES JESS

  • Director
 29,250 2013-02-21 0

ASCHINGER CARL J JR

  • Director
 0 2012-01-30 0

BUPP DAVID C

  • Director
 2,843,130 2011-11-17 0

BLAIR ANTHONY K VP-MANUFACTURING & OPERATIONS

  • Officer
 38,544 2011-05-27 0

RASH DOUGLAS L VICE PRESIDENT, MARKETING

  • Officer
 0 2010-12-21 0

JOHNSON OWEN E

  • Director
 70,000 2010-12-08 0

MILLER FRED B

  • Director
 141,000 2010-06-16 0

AVITAL REUVEN

  • Director
 289,256 2010-03-16 0

WHITLEY J FRANK

  • Director
 61,500 2009-12-30 0

BLAND KIRBY I

  • Director
 0 2009-01-05 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

LATKIN JED - Director - Officer CEO, COO & CFO

2019-05-17 P 1,000 $1.46 a 11,950 11,950.00 direct

LATKIN JED - Director - Officer CEO, COO & CFO

2019-05-16 P 1,500 $1.45 a 10,950 11,950.00 direct

LATKIN JED - Director - Officer CEO, COO & CFO

2019-05-15 P 1,000 $1.45 a 9,450 9,450.00 direct

LATKIN JED - Director - Officer CEO, COO & CFO

2019-05-14 P 2,000 $1.84 a 8,450 9,450.00 direct

BRUCK CLAUDINE - Director

2019-05-13 P 2,550 $1.90 a 7,550 7,550.00 direct

LATKIN JED - Director - Officer CEO, COO & CFO

2019-05-13 P 2,400 $1.91 a 6,450 9,450.00 direct

SCOTT JOHN K JR. - > 10% Owner

2019-03-22 P 357,143 $0.14 a 22,261,565 22,464,350.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments